Helicobacter pylori Infection in Korea, 2013 Revised Edition'/> Helicobacter pylori Infection in Korea, 2013 Revised Edition'/>
Korean J Helicobacter  Up Gastrointest Res Search

CLOSE


Korean J Helicobacter  Up Gastrointest Res > Volume 15(2); 2015 > Article
The Korean Journal of Helicobacter  and Upper Gastrointestinal Research 2015;15(2):95-102.
DOI: https://doi.org/10.7704/kjhugr.2015.15.2.95    Published online June 10, 2015.
Web Survey of Society Members' Recognition of Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea, 2013 Revised Edition
Hyun Joo Song, Ki Nam Shim, Byung Wook Kim
1Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea.
2Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea. shimkn@ewha.ac.kr
3Department of Internal Medicine, The Catholic University of Korea School of Medicine, Incheon, Korea.
2013년도 개정된 한국인 Helicobacter pylori 감염의 진단 및 치료 임상 진료지침에 대한 학회 회원 인지도 웹 설문조사
송현주, 심기남1, 김병욱2
제주대학교 의학전문대학원 내과학교실, 이화여자대학교 의학전문대학원 내과학교실1, 가톨릭대학교 의과대학 내과학교실2
Abstract
BACKGROUND/AIMS
We aimed to evaluate recognition of the 2013 revised guidelines for diagnosis and treatment of Helicobacter pylori infection in Korea by members of the society through a web survey. MATERIALS AND METHODS: We analyzed the respondents' agreement with the 19 guidelines in terms of awareness and adherence. Among 718 physicians, 149 (20.8%) answered the questionnaire by e-mail between October and November 2013. RESULTS: The mean age of the respondents was 40+/-7 years, and the ratio of men to women were 74.5:25.5. The respondents were as follows: professors (36.2%), fellows (31.5%), salaried doctors (17.4%), private practitioners (11.4%), and screening center clinicians (3.4%). Among the 141 respondents, 69.1% had read, 17.3% agreed completely, and 77.3% agreed generally with the guidelines. The respondents indications for eradication were peptic ulcer disease (77.2%), MALT lymphoma (89.3%), and following endoscopic therapy for early gastric cancer (71.1%). However, 42.3% and 48.3% of the physicians administered H. pylori eradication treatment for patients with atrophic gastritis and a family history of gastric cancer, respectively. Triple therapy as first line regimens was administered by 81.2% of the respondents. The duration was one-week for 77.7% and two-weeks for 13.4%. A total of 55.7% prescribed a bismuth-based secondary treatment. When bismuth-based initial therapy failed, a combination of 2 antibiotics that were not used as first-line therapy were used (37.6%). CONCLUSIONS: This web survey was very helpful for analyzing society members' recognition of 2013 revised guidelines. Generally, all the society members followed the guidelines.
Key Words: Helicobacter pylori; Guideline; Internet; Data collection; Societies


Editorial Office
Lotte Gold Rose II Room 917, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-717-5543    Fax: +82-2-565-9947    E-mail: kjhugr@kams.or.kr                

Copyright © 2024 by Korean College of Helicobacter and Upper Gastrointestinal Research.

Developed in M2PI

Close layer
prev next